The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) Trial

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

J. Toole, M. Malinow, L. Chambless, et al.. (2004). JAMA. Cited 1,391 times. https://doi.org/10.1001/JAMA.291.5.565

Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis

J. Spence, H. Bang, L. Chambless, et al.. (2005). Stroke. Cited 262 times. https://doi.org/10.1161/01.STR.0000185929.38534.f3

Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design

J. Spence, V. Howard, L. Chambless, et al.. (2001). Neuroepidemiology. Cited 126 times. https://doi.org/10.1159/000054753

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke

B. Ovbiagele, J. Saver, H. Bang, et al.. (2006). Neurology. Cited 42 times. https://doi.org/10.1212/01.wnl.0000208403.18885.0e

Plasma A&bgr;, homocysteine, and cognition: The Vitamin Intervention for Stroke Prevention (VISP) trial

A. Viswanathan, S. Raj, S. Greenberg, et al.. (2009). Neurology. Cited 38 times. https://doi.org/10.1212/01.wnl.0000339486.63862.db

Vitamin intervention for stroke prevention

J. Toole. (2002). Journal of the Neurological Sciences. Cited 30 times. https://doi.org/10.1016/S0022-510X(02)00265-4

Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.

L. Pettigrew, H. Bang, L. Chambless, et al.. (2008). Atherosclerosis. Cited 22 times. https://doi.org/10.1016/j.atherosclerosis.2007.11.014

Relationship between Non-Specific Prescription Pill Adherence and Ischemic Stroke Outcomes

B. Ovbiagele, Stephen Campbell, A. Faiz, et al.. (2009). Cerebrovascular Diseases. Cited 21 times. https://doi.org/10.1159/000262311

Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial

J. Spence. (2007). Clinical Chemistry and Laboratory Medicine. Cited 12 times. https://doi.org/10.1515/CCLM.2007.325

The challenge of stroke prevention.

D. Hanley. (2004). JAMA. Cited 8 times. https://doi.org/10.1001/JAMA.291.5.621

The Changing Risk Factor Profile of Participants Enrolled in a Secondary Stroke Prevention Trial: Vitamin Intervention for Stroke Prevention

V. Howard, K. Furie, chin-hua wang, et al.. (2006). Neuroepidemiology. Cited 2 times. https://doi.org/10.1159/000096994